These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31009268)

  • 1. An altered composition of the microbiome in microscopic colitis is driven towards the composition in healthy controls by treatment with budesonide.
    Rindom Krogsgaard L; Kristian Munck L; Bytzer P; Wildt S
    Scand J Gastroenterol; 2019 Apr; 54(4):446-452. PubMed ID: 31009268
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical characteristics and patterns and predictors of response to therapy in collagenous and lymphocytic colitis.
    Colussi D; Salari B; Stewart KO; Lauwers GY; Richter JR; Chan AT; Ricciardiello L; Khalili H
    Scand J Gastroenterol; 2015; 50(11):1382-8. PubMed ID: 25997458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review: are lymphocytic colitis and collagenous colitis two subtypes of the same disease - microscopic colitis?
    Rasmussen MA; Munck LK
    Aliment Pharmacol Ther; 2012 Jul; 36(2):79-90. PubMed ID: 22670660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, Clinical Presentation, and Associated Factors of Microscopic Colitis in Northern France: A Population-Based Study.
    Fumery M; Kohut M; Gower-Rousseau C; Duhamel A; Brazier F; Thelu F; Nagorniewicz F; Lamarche F; Nguyen-Khac E; Sabbagh C; Loreau J; Colombel JF; Savoye G; Chatelain D; Dupas JL; ;
    Dig Dis Sci; 2017 Jun; 62(6):1571-1579. PubMed ID: 27659673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Gut Microbiota in Collagenous Colitis Shares Characteristics With Inflammatory Bowel Disease-Associated Dysbiosis.
    Carstens A; Dicksved J; Nelson R; Lindqvist M; Andreasson A; Bohr J; Tysk C; Talley NJ; Agréus L; Engstrand L; Halfvarson J
    Clin Transl Gastroenterol; 2019 Jul; 10(7):e00065. PubMed ID: 31343467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vedolizumab in Refractory Microscopic Colitis: An International Case Series.
    Rivière P; Münch A; Michetti P; Chande N; de Hertogh G; Schoeters P; Ferrante M; Vermeire S; Van Assche G
    J Crohns Colitis; 2019 Mar; 13(3):337-340. PubMed ID: 30329034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral pH-modified release budesonide for treatment of inflammatory bowel disease, collagenous and lymphocytic colitis.
    Gross V
    Expert Opin Pharmacother; 2008 May; 9(7):1257-65. PubMed ID: 18422482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased transmucosal uptake of E. coli K12 in collagenous colitis persists after budesonide treatment.
    Münch A; Söderholm JD; Ost A; Ström M
    Am J Gastroenterol; 2009 Mar; 104(3):679-85. PubMed ID: 19209166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal Infection and Risk of Microscopic Colitis: A Nationwide Case-Control Study in Sweden.
    Khalili H; Axelrad JE; Roelstraete B; Olén O; D'Amato M; Ludvigsson JF
    Gastroenterology; 2021 Apr; 160(5):1599-1607.e5. PubMed ID: 33421519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastroduodenal mucosa in microscopic colitis.
    Koskela RM; Niemelä SE; Lehtola JK; Bloigu RS; Karttunen TJ
    Scand J Gastroenterol; 2011 May; 46(5):567-76. PubMed ID: 21291294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and Management of Microscopic Colitis.
    Pardi DS
    Am J Gastroenterol; 2017 Jan; 112(1):78-85. PubMed ID: 27897155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile Acid Sequestrant Therapy in Microscopic Colitis.
    Northcutt MJ; Gentile NM; Goldstein JL; Yen EF
    J Clin Gastroenterol; 2022 Feb; 56(2):161-165. PubMed ID: 33443968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Characteristics and Treatment Response in Microscopic Colitis Based on Age at Diagnosis: A Multicenter Retrospective Study.
    Kamboj AK; McGoldrick J; Voth E; Penrice D; Tome J; Gujral A; Miller K; Burke KE; Pardi DS; Khalili H
    Dig Dis Sci; 2022 Jul; 67(7):3108-3114. PubMed ID: 34283360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards a new paradigm of microscopic colitis: Incomplete and variant forms.
    Guagnozzi D; Landolfi S; Vicario M
    World J Gastroenterol; 2016 Oct; 22(38):8459-8471. PubMed ID: 27784958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune modulator therapy for microscopic colitis in a case series of 73 patients.
    Cotter TG; Kamboj AK; Hicks SB; Tremaine WJ; Loftus EV; Pardi DS
    Aliment Pharmacol Ther; 2017 Jul; 46(2):169-174. PubMed ID: 28488312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microscopic colitis: an update.
    Tangri V; Chande N
    J Clin Gastroenterol; 2009 Apr; 43(4):293-6. PubMed ID: 19169149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocytic colitis and collagenous colitis: a review of clinicopathologic features and immunologic abnormalities.
    Mahajan D; Goldblum JR; Xiao SY; Shen B; Liu X
    Adv Anat Pathol; 2012 Jan; 19(1):28-38. PubMed ID: 22156832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microscopic colitis: an unfamiliar but treatable disease.
    van der Wouden EJ; Karrenbeld A; Kleibeuker JH; Dijkstra G
    Neth J Med; 2009 Feb; 67(2):41-5. PubMed ID: 19299845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis.
    Miehlke S; Madisch A; Kupcinskas L; Petrauskas D; Böhm G; Marks HJ; Neumeyer M; Nathan T; Fernández-Bañares F; Greinwald R; Mohrbacher R; Vieth M; Bonderup OK;
    Gastroenterology; 2014 May; 146(5):1222-30.e1-2. PubMed ID: 24440672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological and clinical characteristics, and response to treatment in 113 patients with microscopic colitis.
    Rojo E; Casanova MJ; P Gisbert J
    Gastroenterol Hepatol; 2021 Dec; 44(10):671-679. PubMed ID: 33248178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.